AltaThera selected by FDA to participate in a new regulatory program called Model-Informed Drug Development – AltaThera

Company
- Patent Information
Focus
Product
Order
Investor
Contact
News
Sotalol IV PI

AltaThera selected by FDA to participate in a new regulatory program called Model-Informed Drug Development

nextIV Sotalol Donated for Veterinary Research on Ventricular Arrhythmias

Privacy Policy
Terms of Service

©2019 AltaThera Pharmaceuticals LLC. All Rights Reserved